Rockbridge Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-905
| Closed | -$3.75K | – | 496 |
|
|
2022
Q2 | $3.75K | Hold |
905
| – | – | ﹤0.01% | 485 |
|
|
2022
Q1 | $5.47K | Hold |
905
| – | – | ﹤0.01% | 608 |
|
|
2021
Q4 | $7K | Hold |
905
| – | – | ﹤0.01% | 618 |
|
|
2021
Q3 | $8K | Sell |
905
-60
| -6% | -$530 | ﹤0.01% | 552 |
|
|
2021
Q2 | $12K | Hold |
965
| – | – | ﹤0.01% | 505 |
|
|
2021
Q1 | $12K | Hold |
965
| – | – | ﹤0.01% | 487 |
|
|
2020
Q4 | $15K | Buy |
965
+60
| +7% | +$933 | ﹤0.01% | 456 |
|
|
2020
Q3 | $9K | Hold |
905
| – | – | ﹤0.01% | 479 |
|
|
2020
Q2 | $8K | Buy |
+905
| New | +$8K | ﹤0.01% | 456 |
|